• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume9, Issue8

Ki-67 Proliferation Index In Carcinoma Breast: Pitfalls In Assessment

    Cheena Garg, Amit Kumar, Arjun Agarwal, Nitesh Mohan .

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 8, Pages 2915-2921

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Ki-67 proliferation index is used as a prognostic-predictive marker in breast carcinoma and determined using visual hotspots or global counts methods. We studied analytical objectivity and reproducibility using the two methods.
Material and Method: 56 cases of carcinoma breast with Ki-67 (MIB-1antibody) staining on same sections were evaluated by two equally experienced pathologists, blinded to each other using both methods. The values obtained were classified into low, intermediate and high categories and statistical analysis was done using SPSS ver21.0 software.
Result: The mean value of hotspot method was higher whereas global method showed better interobserver reliability.
Conclusion: We recommend global method of Ki-67 evaluation as it has better reproducibility and inter-observer agreement as compared to visual hot spot method. The latter which has a higher mean value may result in change in categorization of Ki-67 index especially at higher end of cut-off in intermediate category, thereby affecting treatment protocols.
Keywords:
    Ki-67 proliferation index average method visual hotspot method
  • PDF (218 K)
  • XML
(2023). Ki-67 Proliferation Index In Carcinoma Breast: Pitfalls In Assessment. European Journal of Molecular & Clinical Medicine, 9(8), 2915-2921.
Cheena Garg, Amit Kumar, Arjun Agarwal, Nitesh Mohan .. "Ki-67 Proliferation Index In Carcinoma Breast: Pitfalls In Assessment". European Journal of Molecular & Clinical Medicine, 9, 8, 2023, 2915-2921.
(2023). 'Ki-67 Proliferation Index In Carcinoma Breast: Pitfalls In Assessment', European Journal of Molecular & Clinical Medicine, 9(8), pp. 2915-2921.
Ki-67 Proliferation Index In Carcinoma Breast: Pitfalls In Assessment. European Journal of Molecular & Clinical Medicine, 2023; 9(8): 2915-2921.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 11
  • PDF Download: 20
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus